1. Home
  2. AMSS vs PMCB Comparison

AMSS vs PMCB Comparison

Compare AMSS & PMCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AMASS Brands Inc. Common Stock

AMSS

AMASS Brands Inc. Common Stock

N/A

Current Price

$0.24

Market Cap

4.2M

ML Signal

N/A

Logo PharmaCyte  Biotech Inc.

PMCB

PharmaCyte Biotech Inc.

N/A

Current Price

$0.37

Market Cap

4.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AMSS
PMCB
Founded
2016
1996
Country
United States
United States
Employees
N/A
2
Industry
Beverages (Production/Distribution)
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.2M
4.0M
IPO Year
2026
2001

Fundamental Metrics

Financial Performance
Metric
AMSS
PMCB
Price
$0.24
$0.37
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
62.0K
★ 99.3K
Earning Date
11-16-2026
12-17-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
$3.71
N/A
Revenue Next Year
$20.00
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.28
$0.30
52 Week High
$2.44
$1.51

Technical Indicators

Market Signals
Indicator
AMSS
PMCB
Relative Strength Index (RSI) 29.50 50.38
Support Level N/A $0.32
Resistance Level $0.39 $0.40
Average True Range (ATR) 0.04 0.04
MACD 0.01 0.01
Stochastic Oscillator 18.97 58.20

Price Performance

Historical Comparison
AMSS
PMCB

About AMSS AMASS Brands Inc. Common Stock

Amass Brands Inc is building a diversified premium beverage platform at the intersection of craft, wellness, and functionality. The company operates in the beverage industry, offering a portfolio that includes spirits, wine, and non-alcoholic products. The company distributes its brands in the United States through wholesale, on-premise, and direct-to-consumer channels. The company has two segments: Wine and Spirits. The majority of the company's revenue is derived from the Wine segment, which offers a portfolio of premium imported and domestic wine brands. Geographically, it operates predominantly in the USA.

About PMCB PharmaCyte Biotech Inc.

PharmaCyte Biotech Inc is a biotechnology company focused on developing cellular therapies for cancer based on its proprietary cellulose-based live cell encapsulation technology, Cell-in-a-Box. The technology is intended to be used as a platform for therapies for several types of cancer, including locally advanced, inoperable pancreatic cancer (LAPC). The current generation of the Company's product candidate is CypCaps. The Company is preparing to commercialize cellular therapies for cancer and advance clinical research and development, including a clinical trial in LAPC using encapsulated live cells. Its candidate therapy involves encapsulating genetically engineered human cells that convert an inactive chemotherapy drug into its active, cancer-killing form.

Share on Social Networks: